//
Andreas Glenthj
Rachael F. Grace
Eduard J. van Beers
Joan-Lluis Vives Corrons
Bertil Glader
Kevin H. M. Kuo
Yan Yan
Paola Bianchi
4Dana-Farber/Boston Children's Cancer and Blood Disorders Center,Boston,United States
UOC di Oncoematologia, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy
Metabolic Support UK,Wrexham,United Kingdom
Stanford University School of Medicine,Stanford, CA,Verenigde Staten
Department of Pediatrics, Palacky University and University Hospital, Olomouc, Czech Republic
Stanford University School of Medicine,Stanford, CA,Verenigde Staten
AGIOS Pharmaceuticals Inc,Cambridge,United States
Department of Pediatrics, Palacky University and University Hospital, Olomouc, Czech Republic
Division of Dermatology, University of Toronto, Toronto,Canada
Division of Dermatology, University of Toronto, Toronto,Canada
Metabolic Support UK,Wrexham,Vereinigtes Königreich
UOC di Oncoematologia, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy
AGIOS Pharmaceuticals Inc,Cambridge,United States
Institute for Leukaemia Research Josep Carreras ENERCA Coordinator,University of Barcelona,Barcelona,Espagne
Agios Pharmaceuticals Inc.,Cambridge,Estados Unidos
Stanford University Medical Center, Stanford, California, United States
Department of Pediatrics,Palacky Unive
UOC di Oncoematologia, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy
Stanford University School of Medicine,Stanford,Estados Unidos
Metabolic Support UK,Wrexham,Regno Unito
Institute for Leukaemia Research Josep Carreras ENERCA Coordinator,Univers
Institute for Leukaemia Research Josep Carreras ENERCA Coordinator,University of Barcelona,Barcelona,Espagne
Van Creveldkliniek Department of Internal Medicine,University Medical Center Utrecht,Utrecht,Pays-bas
Metabolic Support UK,Wrexham,Verenigd Koninkrijk
AGIOS Pharmaceuticals Inc,Cambridge,United States
Van Creveldkliniek Department of Internal Medicine,University Medical Center Utrecht,Utrecht,Pays-bas
UOC di Oncoematologia, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy
4Dana-Farber/Boston Children's Cancer and Blood Disorders Center,Boston,United States
4Dana-Farber/Boston Children's Cancer and Blood Disorders Center,Boston,United States
Department of Hematology, University Hospital Rigshospitalet, Copenhagen, Denmark
Van Creveldkliniek Department of Internal Medicine,University Medical Center Utrecht,Utrecht,Pays-bas
Division of Dermatology, University of Toronto, Toronto,Canada
Division of Hematology,University of Tor
Stanford University, CA
Metabolic Support UK,Wrexham,Соединённое Королевство
Metabolic Support UK,Wrexham,Royaume-uni
Department of Pediatrics, Palacky University and University Hospital, Olomouc, Czech Republic
Agios Pharmaceuticals Inc.,Cambridge,Estados Unidos
U.O. Oncoematologia,Fondazione IRCCS Ca' Granda Ospedale Mag
Agios Pharmaceuticals Inc.,Cambridge,Estados Unidos
4Dana-Farber/Boston Children's Cancer and Blood Disorders Center,Boston,United States
Dana-Farber/Boston Children's Cancer and Blood Disorder Center,B
Institute for Leukaemia Research Josep Carreras ENERCA Coordinator,University of Barcelona,Barcelona,Espagne
Department of Pediatrics, Palacky University and University Hospital, Olomouc, Czech Republic
Metabolic Support UK,Wrexham,Regno Unito
Van Creveldkliniek Department of Internal Medicine,University Medical Center Utrecht,Utrecht,Pays-bas
Agios Pharmaceuticals Inc.,Cambridge,Estados Unidos
Metabolic Support UK,Wrexham,Storbrita
Department of Hematology, University Hospital Rigshospitalet, Copenhagen, Denmark
Department of Hematology,
Department of Hematology, University Hospital Rigshospitalet, Copenhagen, Denmark
Denmark
United States
Netherlands
Venezuela
Canada
United Kingdom
Czech Republic
Italy
N/A
Genetic Disorder
Endocrine/metabolic Diseases (ME)
Pyruvate kinase (PK) deficiency
N/A
N/A
N/A
Observational
Prospective
N/A
NCT03481738
N/A
N/A